PTD modified paclitaxel anti-resistant liposomes for treatment of drug-resistant non-small cell lung cancer

References

• Ai B, Liu H, Huang Y, Peng P. (2016). Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer. Oncotarget 7:44583–95
   PubMed Web of Science ®Google Scholar
• Bai M, Shen M, Teng Y, et al. (2015). Enhanced therapeutic effect of Adriamycin on multidrug resistant breast cancer by the ABCG2-siRNA loaded polymeric nanoparticles assisted with ultrasound. Oncotarget 6:43779–90
   PubMed Web of Science ®Google Scholar
• Behera B, Mukherjee D, Agarwal T, et al. (2016). Cell penetrating peptides from agglutinin protein of Abrus precatorius facilitate the uptake of Imatinib mesylate. Colloid Surf B 140:169–75
   PubMed Web of Science ®Google Scholar
• Biswas S, Deshpande PP, Perche F, et al. (2013). Octa-arginine-modified pegylated liposomal doxorubicin: an effective treatment strategy for non-small cell lung cancer. Cancer Lett 335:191–200
   PubMed Web of Science ®Google Scholar
• Chen CT, Chen YC, Yamaguchi H, Hung MC. (2015). Carglumic acid promotes apoptosis and suppresses cancer cell proliferation in vitro and in vivo. Am J Cancer Res 5:3560–9
   PubMed Web of Science ®Google Scholar
• Cheng L, Huang FZ, Cheng LF, et al. (2014). GE11-modified liposomes for non-small cell lung cancer targeting: preparation, ex vitro and in vivo evaluation. Int J Nanomed 9:921–35
   PubMed Web of Science ®Google Scholar
• Downey CM, Aghaei M, Schwendener RA, Jirik FR. (2014). DMXAA causes tumor site-specific vascular disruption in murine non-small cell lung cancer, and like the endogenous non-canonical cyclic dinucleotide STING agonist, 2′3′-cGAMP, induces M2 macrophage repolarization. PLoS One 9:e99988
   PubMed Web of Science ®Google Scholar
• Egido E, Muller R, Li-Blatter X, et al. (2015). Predicting activators and inhibitors of the breast cancer resistance protein (ABCG2) and P-glycoprotein (ABCB1) based on mechanistic considerations. Mol Pharm 12:4026–37
   PubMed Web of Science ®Google Scholar
• Guo L, Fan L, Ren J, et al. (2012). Combination of TRAIL and actinomycin D liposomes enhances anticancer effect in non-small cell lung cancer. Int J Nanomed 7:1449–60
   PubMed Web of Science ®Google Scholar
• Han HW, Hsu SH. (2016). Chitosan-hyaluronan based 3D co-culture platform for studying the crosstalk of lung cancer cells and mesenchymal stem cells. Acta Biomater 42:157–67
   PubMed Web of Science ®Google Scholar
• Jiang L, Li L, He X, et al. (2015). Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response. Biomaterials 52:126–39
   PubMed Web of Science ®Google Scholar
• Ju RJ, Li XT, Shi JF, et al. (2014). Liposomes, modified with PTD(HIV-1) peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancer. Biomaterials 35:7610–21
   PubMed Web of Science ®Google Scholar
• Kayyali R, Marriott C, Wiseman H. (1994). Tamoxifen decreases drug efflux from liposomes: relevance to its ability to reverse multidrug resistance in cancer cells? Febs Lett 344:221–4
   PubMed Web of Science ®Google Scholar
• Kim HY, Kim S, Pyun HJ, et al. (2015). Cellular uptake mechanism of TCTP-PTD in human lung carcinoma cells. Mol Pharm 12:194–203
   PubMedGoogle Scholar
• Kiss Z, Crilly KS. (1995). Tamoxifen inhibits uptake and metabolism of ethanolamine and choline in multidrug-resistant, but not in drug-sensitive, MCF-7 human breast carcinoma cells. Febs Lett 360:165–8
   PubMed Web of Science ®Google Scholar
• Li XT, Ju RJ, Li XY, et al. (2014). Multifunctional targeting daunorubicin plus quinacrine liposomes, modified by wheat germ agglutinin and tamoxifen, for treating brain glioma and glioma stem cells. Oncotarget 5:6497–511
   PubMed Web of Science ®Google Scholar
• Li XT, Zhou ZY, Jiang Y, et al. (2015). PEGylated VRB plus quinacrine cationic liposomes for treating non-small cell lung cancer. J Drug Target 23:232–43
   PubMed Web of Science ®Google Scholar
• Lima RA, Candido EB, de Melo FP, et al. (2015). Gene expression profile of ABC transporters and cytotoxic effect of ibuprofen and acetaminophen in an epithelial ovarian cancer cell line in vitro. Rev Bras Ginecol Obstet 37:283–90
   PubMedGoogle Scholar
• Lin LT, Chang CH, Yu HL, et al. (2014). Evaluation of the therapeutic and diagnostic effects of PEGylated liposome-embedded 188Re on human non-small cell lung cancer using an orthotopic small-animal model. J Nucl Med 55:1864–70
   PubMed Web of Science ®Google Scholar
• Liu Y, Ran R, Chen J, et al. (2014). Paclitaxel loaded liposomes decorated with a multifunctional tandem peptide for glioma targeting. Biomaterials 35:4835–47
   PubMed Web of Science ®Google Scholar
• Mao Z, Zhou J, Luan J, et al. (2014). Tamoxifen reduces P-gp-mediated multidrug resistance via inhibiting the PI3K/Akt signaling pathway in ER-negative human gastric cancer cells. Biomed Pharmacother 68:179–83
   PubMed Web of Science ®Google Scholar
• Mukherjee AK, Saviola AJ, Burns PD, Mackessy SP. (2015). Apoptosis induction in human breast cancer (MCF-7) cells by a novel venom L-amino acid oxidase (Rusvinoxidase) is independent of its enzymatic activity and is accompanied by caspase-7 activation and reactive oxygen species production. Apoptosis 20:1358–72
   PubMed Web of Science ®Google Scholar
• Perillo E, Porto S, Falanga A, et al. (2016). Liposome armed with herpes virus-derived gH625 peptide to overcome doxorubicin resistance in lung adenocarcinoma cell lines. Oncotarget 7:4077–92
   PubMed Web of Science ®Google Scholar
• Pujari R, Jose J, Bhavnani V, et al. (2016). Tamoxifen-induced cytotoxicity in breast cancer cells is mediated by glucose-regulated protein 78 (GRP78) via AKT (Thr308) regulation. Int J Biochem Cell B 77:57–67
   PubMed Web of Science ®Google Scholar
• Qin C, He B, Dai W, et al. (2014). Inhibition of metastatic tumor growth and metastasis via targeting metastatic breast cancer by chlorotoxin-modified liposomes. Mol Pharm 11:3233–41
   PubMed Web of Science ®Google Scholar
• Qiu JG, Zhang YJ, Li Y, et al. (2015). Trametinib modulates cancer multidrug resistance by targeting ABCB1 transporter. Oncotarget 6:15494–509
   PubMed Web of Science ®Google Scholar
• Song XL, Liu S, Jiang Y, et al. (2016). Targeting vincristine plus tetrandrine liposomes modified with DSPE-PEG2000-transferrin in treatment of brain glioma. Eur J Pharm Sci 96:129–40
   PubMed Web of Science ®Google Scholar
• Wang N, He T, Shen Y, et al. (2016). Paclitaxel and tacrolimus coencapsulated polymeric micelles that enhance the therapeutic effect of drug-resistant ovarian cancer. Acs Appl Mater Inter 8:4368–77
   PubMed Web of Science ®Google Scholar
• Wang SQ, Liu ST, Zhao BX, et al. (2015). Afatinib reverses multidrug resistance in ovarian cancer via dually inhibiting ATP binding cassette subfamily B member 1. Oncotarget 6:26142–60
   PubMed Web of Science ®Google Scholar
• Wang XX, Li YB, Yao HJ, et al. (2011). The use of mitochondrial targeting resveratrol liposomes modified with a dequalinium polyethylene glycol-distearoylphosphatidyl ethanolamine conjugate to induce apoptosis in resistant lung cancer cells. Biomaterials 32:5673–87
   PubMed Web of Science ®Google Scholar
• Wang Z, Xu Z, Niu Z, et al. (2015). Epieriocalyxin A induces cell apoptosis through JNK and ERK1/2 signaling pathways in colon cancer cells. Cell Biochem Biophys 73:559–64
   PubMed Web of Science ®Google Scholar
• Wen S, Fu X, Li G, et al. (2016). Efficacy of tamoxifen in combination with docetaxel in patients with advanced non-small-cell lung cancer pretreated with platinum-based chemotherapy. Anticancer Drugs 27:447–56
   PubMed Web of Science ®Google Scholar
• Yang YT, Shi Y, Jay M, Di Pasqua AJ. (2014). Enhanced toxicity of cisplatin with chemosensitizer phenethyl isothiocyanate toward non-small cell lung cancer cells when delivered in liposomal nanoparticles. Chem Res Toxicol 27:946–8
   PubMed Web of Science ®Google Scholar
• Zeng F, Ju RJ, Li XT, Lu WL. (2014). Advances in investigations on the mechanism of cancer multidrug resistance and the liposomes-based treatment strategy. J Pharm Investig 44:493–504
   Google Scholar
• Zeng F, Ju RJ, Liu L, et al. (2015). Application of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triple-negative breast cancer. Oncotarget 6:36625–42
   PubMed Web of Science ®Google Scholar
• Zhang H, Hu H, Zhang H, et al. (2015). Effects of PEGylated paclitaxel nanocrystals on breast cancer and its lung metastasis. Nanoscale 7:10790–800
   PubMed Web of Science ®Google Scholar
• Zhang X, Li Y, Cheng Y, et al. (2015). Tat PTD-endostatin: a novel anti-angiogenesis protein with ocular barrier permeability via eye-drops. Biochim Biophys Acta 1850:1140–9
   PubMed Web of Science ®Google Scholar
• Zhao YZ, Lin Q, Wong HL, et al. (2016). Glioma-targeted therapy using Cilengitide nanoparticles combined with UTMD enhanced delivery. J Control Release 224:112–25
   PubMed Web of Science ®Google Scholar
• Zhou J, Zhao WY, Ma X, et al. (2013). The anticancer efficacy of paclitaxel liposomes modified with mitochondrial targeting conjugate in resistant lung cancer. Biomaterials 34:3626–38
   PubMed Web of Science ®Google Scholar